LeMaitre Vascular, Inc. (LMAT)
$80.69+1.32%Close
BUYRECOVERY · day 28
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.8B
- Beta
- 0.47
- Div yield
- 1.20%
- P/E (TTM)
- 27.26
- Short % float
- 8.18%
- Days to cover
- 6.9
- SI change
- +2.7%
- 1W
- +2.19%
- 1M
- +2.40%
- vs SPY 1W
- +1.03%
- vs SPY 1M
- -0.59%
Industry peers
FMP comparable companies · ranked by market cap
- MDTSELLMedtronic Plc$113.3BBEARQ 14$88.48+0.83%
- BSXSELLBoston Scientific Corporation$63.5BRECOVERYQ 6$42.73+1.64%
- PENSELLPenumbra, Inc.$12.6BBULLQ 27$319.40+0.59%
- TFXSELLTeleflex Incorporated$5.5BBEARQ 11$125.12+0.75%
- MMSISELLMerit Medical Systems, Inc.$5.2BBEARQ 13$87.21+2.30%
- AORTSELLArtivion, Inc.$1.0BCRISISQ 3$21.26+0.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on LMAT?
- LOPJLB’s latest quantitative signal on LeMaitre Vascular, Inc. (LMAT) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is LMAT in?
- LeMaitre Vascular, Inc. (LMAT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does LeMaitre Vascular, Inc. (LMAT) do?
- Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins…